Transgender people are a diverse population aff ected by a range of negative health indicators across high-income, middle-income, and low-income settings. Studies consistently document a high prevalence of adverse health outcomes in this population, including HIV and other sexually transmitted infections, mental health distress, and substance use and abuse. However, many other health areas remain understudied, population-based representative samples and longitudinal studies are few, and routine surveillance eff orts for transgender population health are scarce. The absence of survey items with which to identify transgender respondents in general surveys often restricts the availability of data with which to estimate the magnitude of health inequities and characterise the population-level health of transgender people globally. Despite the limitations, there are suffi cient data highlighting the unique biological, behavioural, social, and structural contextual factors surrounding health risks and resiliencies for transgender people. To mitigate these risks and foster resilience, a comprehensive approach is needed that includes gender affi rmation as a public health framework, improved health systems and access to health care informed by high quality data, and eff ective partnerships with local transgender communities to ensure responsiveness of and cultural specifi city in programming. Consideration of transgender health underscores the need to explicitly consider sex and gender pathways in epidemiological research and public health surveillance more broadly.
Introduction
Transgender people are those whose assigned sex at birth diff ers from their current gender identity or expression, and they represent a diverse population across regions and within countries worldwide (panel 1). 1, 2 Although accurate data about the size of the transgender population globally are absent and numbers depend on the defi nition of transgender used, estimates suggest a prevalence of 0·3-0·5% for people who identify as transgender 3 (see also paper 1 of this Series
• A comprehensive public health approach to address the health of transgender people requires access to gender affi rmation services, evidence-based health-care delivery systems, and eff ective partnerships with local transgender communities • The health-related vulnerabilities among transgender people underscore the need to explicitly consider sex and gender pathways and mechanisms in epidemiological research and public health surveillance more broadly • Multisector partnerships linking health with advocacy, social justice, and human rights are crucial to address the public health needs of transgender people across the world • Lack of standardised survey items on population-based surveys to identify transgender respondents limits existing public health surveillance eff orts and availability of representative samples • The global disease and health burden of transgender people remains understudied, particularly the impact of stigma, discrimination, violence, and other social and structural factors that aff ect the health of this underserved population, as well as interventions to mitigate stigma • Despite substantial gaps in empirical research, there are suffi cient actionable data highlighting unique biological, behavioural, social, and structural contextual factors surrounding health risks and resiliencies for transgender people that need interventions • Consistency of defi nitions for health surveillance and research initiatives that include transgender people are essential, including dedicated funding to support these eff orts participants or men who have sex with men (MSM) were not disaggregated by gender identity (unless data were analysed separately and meaningful inferences could be made about transgender people). Because the overall objective was to obtain epidemiological data about transgender people, sources were not excluded on the basis of quality provided that they met all the inclusion criteria and exclusion criteria (panel 2). First and second reviewers (RM and CEH) did parallel screening of titles found in the search. If one or both reviewers selected the abstract, the full article was reviewed. If at the full article review there was a disagreement between the fi rst two reviewers about data extraction, a third reviewer (SLR) resolved the disagreement.
We created and refi ned a codebook to guide data abstraction using a collaborative consensus-based process among the authors. Health-related outcome categories were identifi ed and used to synthesise and further organise the literature reviewed. The team incorporated principles from grounded theory, 16 whereby codes were iteratively grouped into concepts and concepts into categories. Six health-related outcome categories emerged. Through this process it became apparent that stigma and discrimination were not only determinants of health (illness), but also important outcomes themselves, for transgender populations globally.
We also conducted an expert consultation with selected transgender health researchers, and additional articles that were recommended and that satisfi ed the inclusion criteria were included for data abstraction. We captured the number of unique studies, as well as the number of datapoints-for example, if an article reported four health
Panel 1: Defi nitions: transgender people and gender minorities
Transgender people have a current gender identity or expression that is diff erent from the sex assigned to them at birth. The term gender minority was introduced in 2011 as part of the landmark Institute of Medicine report commissioned by the US National Institutes of Health (NIH) entitled The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. 1 Gender minority is meant to be an inclusive umbrella term which includes people who identify as transgender or have other genders. Transgender people have diverse sexual orientation identities, attractions, and behaviours.
Panel 2: Diff erentiating transgender people from people who are intersex
Intersex people, also known as people with disorders of sex development (DSD; or in the terms of the intersex community, diverse sexual development 10 ), are those born with bodies that vary from both male and female bioanatomies, including diff erences of the chromosomes, gonads, genitals, or other secondary sex characteristics. Some intersex/DSD people consider themselves to be transgender; however, most do not. This research synthesis does not include a review of intersex/DSD research. Many primary issues in intersex/DSD health are diff erent from those in transgender people (such as the need for infant genitoplasty and gonadectomy, ongoing care for intersex/DSD adults, iatrogenic eff ects of genital surgery and gonad removal). [10] [11] [12] [13] [14] [15] The heterogeneity and complexity of intersex/DSD health warrants its own research synthesis, which is beyond the scope of the present paper.
Panel 3: Evolving terminologies
In public health research, transgender populations are categorised according to assigned sex at birth and gender identity. This is because some health indicators (eg, prostate health) are only applicable for people assigned a male sex at birth. The terms trans feminine refers to transgender people assigned a male sex at birth who are on the transgender spectrum-identifying as women, female, male-to-female (MTF), transgender women, trans women, and many other diverse gender minority identities across the world (such as hijra, kathoey, travestis, and waria). The term trans masculine describes transgender people assigned a female sex at birth who are on the transgender spectrum-identifying as men, male, female-to-male (FTM), transgender men, trans men, and many other diverse gender minority identities (genderqueer, stud, aggressive, Sadhin). Greater attention to non-binary genders is needed in research, including consideration of transgender people who do not identify as feminine or masculine, or who integrate both. Transgender people exist all over the world. Defi nitions and terminology continue to dynamically evolve to describe the population across diff erent local, national, and global contexts. outcomes, it contributed four datapoints to the review. Similarly, if data were reported for specifi c subgroups (eg, mental health prevalence estimates for trans feminine and trans masculine people separately), these were counted as unique datapoints and extracted accordingly (panel 3).
Overall research trends
We identifi ed 116 studies in 30 countries. Table 1 presents the health outcome studies and key data extracted from each study by region, country, and author. victimisation, and sex work. Figure 1 shows the geographic distribution of current studies in transgender health. Most of the available research was from the USA. Several countries had a single study (eg, Mexico) or between two and fi ve studies (eg, Canada, Australia, Iran). No country except for the USA had six or more studies reporting data about transgender health. Indeed, for the majority of countries no data were available, and for many, only a single study existed. Only one study was available from sub-Saharan Africa. This gap in research is important to consider in terms of the generalisability of current health research across regions and geographical settings. We noted a growing interest in transgender health research over time, particularly in the most recent years (2013 and 2014), as shown in fi gure 2. We also noted a dearth of research about transgender children, adolescents, and young people, with only 15 studies in these populations.
Distribution of studies by sex and gender
The distribution of studies by natal sex (sex assigned at birth) is depicted in fi gure 3. The majority of studies focused on natal males. Because operationalisation of "transgender" was inconsistent, generalisation of scientifi c fi ndings by gender identity was diffi cult. 
Methodological limitations in current research
The most common study design was cross-sectional (90 of 116, 78% of studies). We noted a dearth of longitudinal data (seven of 116, 6% of studies), and identifi ed only one randomised controlled effi cacy trial 118 of an intervention to improve the health of transgender people globally; two studies 23, 128 used a before-and-afterintervention design. Only three studies 68, 99, 100 were identifi ed that used probability-based sampling methods (three of 116, 3%). Many studies used convenience sampling methods and deployed multiple sampling strategies simultaneously (eg, online, venue based, peer referral, and snowball sampling). Some sampling schemes were more focused-for example, clinic samples (29 of 116, 25%), exclusively internet-based samples (17 of 116, 15%), or respondent-driven samples (eight of 116, 7%). Most studies (95 of 116, 82%) were descriptive, only presented prevalence data (predominately unadjusted prevalences), and did not present any measures of association between risk factors or social determinants and health outcomes. Few studies compared transgender and non-transgender people (eg, by off ering comparative data); most were within-group studies that did not allow documentation of health inequities.
Datapoints categorised by health outcome domain
Overall 981 unique health-related datapoints were identifi ed from the 116 studies. Figure 4 presents these datapoints grouped into six health-related outcome categories by frequency: (1) 
stigma and discrimination (eg, internalised stigma, termination of employment), and (6) general health (eg, diabetes, cancer). The available data show that transgender populations worldwide face a high burden of adverse health and disease outcomes. We briefl y summarise data for each health outcome category.
Mental health
Mental health is the most commonly studied area of transgender health (n=303 datapoints; 31%). The majority of data focuses on mood disorders (n=96, 32%), suicidal and non-suicidal self-injury (n=50, 17%), and anxiety disorders (n=44, 15% 54 and 63% (CESD 20 or higher) in a sample of 230 male-to-female transgender people. 40 Studies using a clinical diagnosis of depression show lower prevalences than those using screening tools. For example, 31% of 207 MTF individuals were in the clinical range of the Minnesota Multiphasic Personality Inventory in Amsterdam 88 and 36% of 253 transgender people had a current major depressive episode in an Australian study. 115 Understanding risk factors for mental health problems is crucial to decreasing global mental health morbidity, yet remarkably few studies have contributed to such an understanding in transgender people. The majority of mental health research (n=161 of 303 datapoints, 53%) reported prevalence data only. Measures of association between risk factors and mental health conditions are an important area for future research eff orts. Additional gaps in mental health research included a scarcity of studies examining post-traumatic stress disorder or traumatic stress (n=3 datapoints), which is surprising, LGBT=lesbian, gay, bisexual, transgender. MSM=men who have sex with men. NS=not specifi ed. RDS=respondent driven sampling. 
Sexual and reproductive health
Sexual and reproductive health was the second most frequently studied area of transgender health (n=219 of 981 datapoints; 22%). The number of datapoints related to sexually transmitted infections (STIs) compared with those for other sexual and reproductive health outcomes is infl ated because many studies of STIs tested for several specifi c organisms (eg, gonorrhoea and chlamydia), thereby creating multiple datapoints. Transgender women are disproportionately aff ected by HIV and other STIs, so it may not be surprising that 75% (163 of 219) of the sexual and reproductive health outcomes reported include HIV or STI prevalence. However, when the data are examined by assigned sex at birth, it becomes clear that this focus on HIV and STIs refl ects a focus on transgender people assigned a male sex at birth. The fi ndings also show that other sexual and reproductive health concerns receive little attention in research among transgender populations. For example, only 15 datapoints addressed non-infectious reproductive health concerns, and none addressed fertility or pregnancy.
Substance use
Substance use was the third most frequently studied health indicator (n=193 of 981 datapoints). Data most commonly focused on alcohol (n=35 datapoints, 18%), marijuana (n=25 datapoints, 13%), any illicit drug use (type not specifi ed, n=16 datapoints, 8%), and tobacco use (n=14 datapoints, 7%). A noteworthy fi nding was that research on substance abuse, dependence, or disorder only comprised 5% of substance use data (n=10 datapoints). Substance use outcomes were heterogeneous and inconsistently operationalised across datapoints, including time of recall (eg, last 30 days, last 3 months, past 6 months, last year, lifetime), which made comparison across studies diffi cult. Substance use has been conceptualised as a coping mechanism to manage minority stress; 135 however, data examining this association among transgender people are scarce. 
Violence and victimisation
Research on experiences of violence, victimisation, or both among transgender people faces methodological challenges, most commonly the use of unstandardised and often non-validated measures of violence and victimisation. Despite these limitations, research shows a high burden of violence and victimisation experiences in transgender people globally. Overall, 105 datapoints were identifi ed examining violence or victimisation in transgender people, of which 80 datapoints (76%) presented prevalence data only. The median prevalence estimate for experience of violence or victimisation was 44%. Types of violence or victimisation datapoints were sexual (34%), physical (17%), psychological or emotional (7%), verbal (4%), or type not specifi ed (38%). Verbal and psychological or emotional violence and victimisation appear to be under-researched, which highlights the need for studies to include multiple dimensions of abuse.
Stigma and discrimination
Only 14 articles (93 datapoints) in the published literature included stigma or discrimination as health outcomes. Of these 14 studies, the majority (n=10) were conducted in North America. Chile, Argentina, and Iran were the only other countries that published data on stigma or discrimination against transgender people as health outcomes, leaving notable gaps in data from regions outside North and South America. A little over half (54%) of outcomes specifi cally addressed stigma and discrimination in health care, including the occurrence of denial of care and postponement of care due to stigma. However, there remains a dearth of literature on the outcomes of interventions designed to reduce antitransgender stigma and discrimination. Clearly, more research is needed to better understand how to address stigma and discrimination to improve health-care access and use for transgender populations (panel 4).
General health
The general health of transgender people is the least researched aspect of the transgender global burden of disease. The general health category-which included outcomes such as mortality, diabetes, hormone use, metabolic syndrome, and cancer-had the fewest datapoints (n=68 of 981 datapoints), with 40 distinct health indicators, 28 of which had only a single data point. The majority of research (77%, n=52) reported unadjusted prevalence estimates only.
Current gaps and opportunities
For transgender people, health inequities are hypothesised to arise from systematic exposure to multiple, intersecting social stressors, including legal and other structural factors that are a result of being part of a socially marginalised group. 140 Social and economic exclusion are therefore conceptualised as causal pathways to adverse health-however, we found very few studies actually linking these social stressors to health indicators. Furthermore, study designs were largely cross-sectional, which limited the ability to make causal inferences. Also scarce were intervention studies examining changes in health status alongside implementation of heath behaviour or other social and structural change inter ventions to improve the lives of transgender people. Studies of legal issues and their eff ect on transgender health are needed, including research on structural factors relating to human rights, such as criminalisation (related to gender identity and expression as well as sex work) and legal recognition.
The way forward: recommendations
We now off er recommendations based on our research synthesis to guide future health research focused on transgender populations. 
Panel 4: Gender affi rmation: a key determinant of transgender health
A key social determinant of health for transgender populations worldwide is gender affi rmation, which has been defi ned as an interpersonal and shared process through which a person's gender identity is socially recognised. [136] [137] [138] However, gender affi rmation is not only social-social recognition of gender also involves other institutions, such as health care and law. Gender affi rmation can thus be conceptualised as having four core facets: social (eg, name, pronoun), psychological (eg, internal, felt self), medical (eg, cross-sex hormones, surgical intervention, other body modifi cation), and legal (eg, legal gender markers, name change). Gender affi rmation depends on a range of factorsincluding context and setting (country and region) and issues relating to accessibility of cross-sex hormones (in terms of availability of medications, accessibility to culturally competent health-care providers), socioeconomics and poverty, criminalisation of sexual and gender minorities, legal barriers to changing gender markers and identity recognition, and so on. There is no single path to gender affi rmation-no single approach describes how transgender people affi rm and embody their gender. 139 Some people may socially, but not medically, affi rm their gender; others may socially and medically but not legally do so. Gender affi rmation sometimes, but not always, conforms to binary categories of being female or male. Non-binary refers to having a transgender identity that does not use female or male dichotomies as reference points.
Count transgender populations
Social determinants, such as age, sex, gender, race, and socioeconomic status, shape the health status of people across the world. WHO defi nes social determinants of health as "the conditions in which people are born, grow, live, work and age" and states explicitly that "these circumstances are shaped by the distribution of money, power and resources at global, national and local levels". 141 Social inequalities resulting from social determinants are conceptualised as driving health inequities. 142 Health inequities refer to avoidable, remediable, unfair health inequalities between populations. 142 A social determinants perspective explicitly links reductions in health inequality to achievement of health equity. 143 Health inequality monitoring refers to the systematic tracking of health inequalities over time, including measures of the magnitude of disparities in the face of interventions such as policies, programmes, and practices. 144 Equity stratifi ers refer to the dimensions of social inequalities being monitored (such as place of residence, or race or ethnicity). 144 Few population level data exist with which to monitor the health of transgender people worldwide, because routine national and international health surveillance eff orts in most countries do not assess gender identity as an equity stratifi er. This omission creates a major gap in the ability to further understand the health inequities burdening transgender people (panel 5). It is also a missed opportunity to understand the relation between intersecting social statuses (such as disability status and caste) and health. There is a need for surveillance defi nitions of transgender people for global use. Studies restricting samples to people with diagnosed gender identity disorder or gender dysphoria do not capture the range of transgender people who comprise the overall population, such as those with non-binary transgender identities.
As Winter and colleagues described in paper 1 of this Series, 4 a two-step method is recommended to capture health-related data by transgender status. 3, 117, 149, 150 This method uses assigned sex at birth and current gender identity to cross-classify respondents as transgender (discordant sex and gender responses) or non-transgender (concordant sex and gender responses). It also allows diverse gender identities to be captured. Researchers have operationalised the two-step method using a range of question and response options (panel 6). Methods have also diff ered as to the order of question asking (sex followed by gender identity, or vice versa) and whether respondents are asked to select one gender identity option or are allowed to select multiple options. The strength of a two-step method is that it explicitly captures dimensions of both natal sex and current gender identity. It also permits categorisation of subpopulations of transgender people by natal sex and gender identity. A two-step method has not been used widely across the world. Studies are needed that implement this approach in diff erent contexts and settings using consistent defi nitions of transgender. We recommend that special care be taken in designing instructions and introductory text for the two-step method, including adaptations for the specifi c geographical context in terms of language and cultural understandings of sex and gender. Training of interviewer staff and research teams is also recommended, as well as a process to confi rm transgender responses in order to minimise misclassifi cation bias.
Put the gender back into transgender health
Sex and gender are determinants of health across a wide variety of geographical contexts. 141, [159] [160] [161] [162] [163] [164] Causal mechanisms for poor health are related to both sex and gender; however, sex and gender are commonly confl ated in research. 159 For example, terms referring to assigned sex at birth ("male" and "female") and gender identity ("men" and "women") are commonly used interchangeably in the scientifi c literature, including in transgender research. This practice leads to a lack of attention as to whether health diff erences are due to sex, gender, both, or neither, 159 which aff ects understanding of health inequities. Synthesis of research on the health of transgender people reveals gaps in the specifi city and operationalisation of sex and gender diff erences in population research more broadly.
Development of new conceptual models and integration and testing of existing frameworks is needed to guide research in transgender population health. Several conceptual models have been applied to transgender health, including social determinants and social ecological models, 141, 165 gender affi rmation, 136 gender minority stress, 58, 135, 166 syndemic production, 167 and health and human rights approaches. 2, 168 These models overlap in their shared recognition that multiple and intersecting levels of risk and resiliency shape the health of transgender people and that, therefore, multilevel contextually relevant interventions are necessary. However, these models do not apply a gender analysis, 159 a
Panel 5: The right to inclusion in health surveillance
A fi rst-line argument made for non-inclusion of measures to identify transgender people in routine health surveillance eff orts has been the small population size. How large is the transgender population globally? It depends how the population is measured. Over the past 15 or so years there has been a paradigm shift in transgender health from a disease-based model (transgender as disorder or mental health diagnosis) to an identity-based model (transgender as identity). 4, 132, 139 Conceptualising transgender people as having diverse, non-pathological genders rather than as disordered redefi nes how a case is operationalised and measured in health research. 145 Such redefi nition of a case also necessarily aff ects prevalence estimates as to the number of transgender people in the world and, potentially, estimation of the distribution, burden, and magnitude of disease inequity in the population. Still, most conservative estimates suggest that 0·1-0·5% of the world's population might be transgender. 146, 147 Assuming that the world's population is approximately 7 billion people, 148 the global population of transgender people might be estimated at 7 million to 35 million. That said, does the number of transgender people matter more than the fact that the population is so grossly underserved worldwide?
social epidemiological approach that explicitly considers socially derived gender exposures and outcomes, sexlinked physiological or biological diff erences, and the interplay of both gender and sex. 158, 159, 169, 170 Transgender people share many of the same risks and social and structural determinants of disease, health, and wellbeing as non-transgender people (such as socioeconomic status). However, transgender people also experience unique biological, behavioural, social, and structural contextual factors surrounding health risks and resiliencies-including those related to challenging the congruence or confl ation of sex and gender such as legal recognition of gender identity. We therefore recommend that future research in transgender population health use a gendered situated vulnerabilities framework to investigate whether and how sex-gender mechanisms 159 shape health-related risks and resiliencies for population health outcomes.
Gendered situated vulnerabilities refer to the ways in which health is shaped by the distribution of power along lines of gender. 171, 172 The vulnerabilities transgender people face regarding health are related to challenging gendered relations of power and policing of gender by social structures. We refer to these as situated because the health risks and resiliencies facing transgender populations cannot be understood without the multilevel sexed and gendered contexts that shape them. We use the term vulnerabilities to describe the ways that these contexts put transgender people "at risk for risk". 173, 174 We do not conceptualise transgender people as an inherently vulnerable population; but rather, view this community as a population facing sex and gender related situated vulnerabilities for diff erent health conditions. As shown in the synthesis of current research, some of the health conditions diff erentially distributed by transgender status include mental health, infectious diseases, and substance use and abuse.
Integrate health and human rights and multi-sectorial approaches
Transgender people have the right to legal recognition of their gender identity, access to gender affi rmation, and a right to self-determination and autonomy. [175] [176] [177] [178] Although the Offi ce of the UN High Commissioner for Human Rights denounces widespread discrimination against transgender people, 7 systematic social and economic marginalisation, stigma, pathologisation, discrimination, violence, and other human rights violations, including those in health care, continue to drive or exacerbate health inequities. To improve the health and access to health care of transgender people globally requires a wide array of stakeholders and mobilisation of diverse multi-sector partnerships. Many barriers to health care and adverse health risks are addressable through law and policy, and some countries have begun to do so through gender identity laws, legislation about gender-affi rmative care, and anti-discrimination and protective measures.
For example, in 2012, the Argentinian Senate passed the fi rst gender identity law in the world, which authorises transgender people to change their legal gender markers through a simple administrative process, with improved access to hormonal treatments or surgical procedures (with the only requirement being informed consent, in accord with the standards of care endorsed by the World Professional Association for Transgender Health), 179, 180 and under governmental coverage. 181 Evaluation of the eff ect of these legal changes and improvements on the health of transgender people is needed. Implementation science, an emerging domain of methods aiming to harness generalisable information that can inform the eff ectiveness of programmes and policies, 182 is well suited for such evaluations.
Transgender health research is not without challenges. Public health researchers must work together with policy makers, health-care providers, and communities and Standardisation of data collection to routinely monitor health and disease distribution among transgender people represents a crucial step towards improving their health. A two-step method is recommended 117, [151] [152] [153] by organisations including the World Professional Association for Transgender Health (WPATH). 154 Appropriate adaptations to the two-step method are needed in diff erent geographical regions, cultures, and languages.
Reisner and colleagues 155 in 2014 implemented the two-step method in the Growing Up Today Study (GUTS), a US prospective cohort of more than 16 000 young people enrolled in 1996.
Step 1 asked: "What sex were you assigned at birth, on your original birth certifi cate? (check one)" with response options "female" and "male". Step 2 asked: "How do you describe yourself? (check one)" with response options "female", "male", "transgender", "do not identify as female, male, or transgender". Cross-tabulation of these questions gives a two by four contingency table with eight cells showing diff erent sex and gender combinations (table 3) . Overall, 0·33% of the cohort self-identifi ed as transgender or another gender minority in 2010.
The two-step approach can not only help to understand population size and health inequities facing transgender people, but can also aid in explicit consideration of sex and gender diff erences more broadly-and health inequities that may be due to assigned sex, current gender, both, or neither. The two-step method thus facilitates a gender analysis in population health. [156] [157] [158] Assigned sex at birth their political organisations to address systematic institutionalised marginalisation. In general, social, ethnic, and psychological aspects of research are not judged to be high on the hierarchy of evidence-forpractice. 183, 184 This problem is compounded by the challenges of researching a discriminated population in view of institutionalised censure, and in some cases criminalisation, of not only transgender communities themselves, but also the researchers and clinicians who engage with them. In most countries, transgender issues are not included in formal training curricula for medicine, epidemiology, public health, education, legal, and social service systems, shaping a poor foundation for research and core competency in transgender health. Integration of public health practice, research, education, advocacy, and funding is critical to address the health needs of transgender people and their allies seeking to understand and ameliorate transgender health disparities.
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Engage transgender people: a participatory population perspective
Within transgender communities, immediate survival needs may supersede perceived health risks and undermine traditional research approaches-research may seem to have little meaning and relevance to people's lives. Poverty, food insecurity, mobility, and security issues might aff ect research participation and attrition rates, as might intersectional issues of sex work, refugee status, and homelessness. Inclusion of transgender people in public health eff orts and working with the local community and its political organisations in each geographical area to advance transgender health and human rights agendas is essential. The use of a "participatory population perspective" 185 and communitybased participatory research principles 186 represents an important future step to ensure that health-related research and interventions are responsive to the real-life issues that transgender people face. This means conducting research "with" and not "on" transgender populations, 187 as well as being transparent in methodological sections of research articles about whether and how transgender communities were engaged in the research process. Meaningful engagement of transgender people will ensure that research is culturally specifi c to local community needs, that research questions and surveys are gender affi rming, and that the scientifi c approach (eg, study design, sampling) is appropriately aligned with and feasible for the study population.
Limitations of the review
In view of the lack of consistent defi nitions within research among transgender populations, a synthesis of transgender population health requires a complex set of diverse search terms and keywords to accurately identify the current health research (see appendix). Notably, the term "transgender" was only added to PubMed as a MeSH term in 2013. From 2001 to 2012, "transsexualism" was the index term. In the USA, the phrase gender minority has been used to describe transgender people, in order to include diverse gender identities, not just people who self-identify as transgender. 1 "Gender minority" is currently not indexed. We recommend that it be added as a MeSH term.
Some data characterising transgender populations did not satisfy the objectives of the review. Data describing sexual satisfaction or quality of life were not included because these measures are often reported in clinical studies of gender reassignment surgical outcomes, whereas our focus in this review was on public health studies; we refer readers to recent reviews of gender reassignment outcomes. 8, 9 Studies examining neuroanatomical or neuropsychological diff erences between transgender populations were excluded. These data are important, especially as new surgical procedures are developed, but they were outside of the scope of the present review.
A noteworthy limitation of this synthesis pertains to the fact that we reported data at the level of datapoints in some instances, rather than at the study level. This approach could have infl ated some estimates, since studies with more datapoints contributed more data. Thus, the count of datapoints presented in this review is not to be interpreted as a measure of the quality of data. We also excluded qualitative studies, which are a rich source of inquiry.
This review was limited to peer-reviewed literature. Many non-peer reviewed sources from WHO, the Pan American Health Organization, the Public Health Agency of Canada, UNAIDS, the US Centers for Disease Control, and additional health agencies and organisations, including grassroots community-based needs assessments, provide invaluable data. Partnerships between community members and researchers to collect data represent an important step in improving transgender health research worldwide.
Conclusions
The global disease and health burden of transgender people remain understudied, particularly in relation to the eff ects of stigma, discrimination, social, and structural factors that aff ect the health of this underserved population. 48 Unavailability of standardised survey items to identify transgender respondents limits existing health surveillance eff orts. Lack of consistent operationalisation of transgender status across studies limits generalisability of fi ndings. Use of a two-step approach to standardise data collection in health-modifi ed for the specifi c geographical context, language, and locale-will allow researchers, policy makers, and transgender people themselves to add to monitor and evaluate eff orts to achieve health equity. Measuring sex and gender dimensions in health research will contribute to understanding and ameliorating health inequities for all.
Despite substantial gaps in empirical research, there are suffi cient actionable data highlighting unique biological, behavioural, social, and structural contextual factors surrounding health risks and resiliencies for transgender people that need interventions. 48 Studies are needed that conceptually integrate and examine transgender-specifi c social determinants of health, including incorporating a framework of gendered situated vulnerabilities. An important next step will be a comprehensive public health approach that includes access to gender affi rmation (in a social, psychological, medical, and legal context), improved health systems informed by high quality data, and eff ective partnerships with local transgender communities to ensure responsiveness of and cultural specifi city of programming. Dedicated funding to ensure consistency of defi nitions for health surveillance and research initiatives involving transgender people is essential to inform evidence-based decisions about the scale and content of programmes. Multisector partnerships that integrate health and human rights are a crucial next step to advance social justice and ultimately the health of transgender people worldwide.
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